##  [Novartis presents results from first global registration trial of CTL019 in pediatric and young adult patients with r/r B-ALL](/us-en/news/media-releases/novartis-presents-results-from-first-global-registration-trial-ctl019-pediatric-and-young-adult-patients-rr-b-all-0 "Novartis presents results from first global registration trial of CTL019 in pediatric and young adult patients with r/r B-ALL") 

  Dec 03, 2016